Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

Zhang, Xinmei, Yeung, Dennis C.Y., Karpisek, Michal, Stejskal, David, Zhou, Zhi-Guang, Liu, Feng, Wong, Rachel L.C., Chow, Wing-Sun +3 more·2008·Diabetes
DOI 10.2337/db07-1476

Cited by (907)

Items 701–800 of 907

  1. A cafeteria diet alters the decision making strategy and metabolic markers in Sprague-Dawley male rats
    Alessandro Virtuoso, Björn Forkman, David A. Sarruf, Pernille Tveden‐Nyborg, Dorte Bratbo Sørensen · 2017 · Applied Animal Behaviour Science
  2. Single-Arm 8-Week Ad Libitum Self-Prepared Paleo Diet Reduces Cardiometabolic Disease Risk Factors in Overweight Adults
    Melissa M. Markofski, Kristofer Jennings, Chad Dolan, Natalie A. Davies, Emily C. P. LaVoy, Edward J. Ryan, Andres E. Carrillo · 2019 · American Journal of Lifestyle Medicine
  3. Association of serum fibroblast growth factor 21 and urinary glucose excretion in hospitalized patients with type 2 diabetes
    Rui Zhang, Xiaoling Cai, Yongrui Du, Liu Liu, Xueyao Han, Wei Liu, Siqian Gong, Xianghai Zhou, Xiangqing Wang, Xin Wen et al. · 2020 · Journal of Diabetes and its Complications
  4. Plasma FGF-21 and Sclerostin Levels, Glycemia, Adiposity, and Insulin Sensitivity in Normoglycemic Black and White Adults
    NKIRU A. UMEKWE, Ibiye Owei, Frankie B. Stentz, Samuel E. Dagogo-Jack · 2021 · Journal of the Endocrine Society
  5. Plasma Tsukushi Concentration Is Associated with High Levels of Insulin and FGF21 and Low Level of Total Cholesterol in a General Population without Medication
    Masato Furuhashi, Yukimura Higashiura, Akiko Sakai, Masayuki Koyama, Marenao Tanaka, Shigeyuki Saitoh, Kazuaki Shimamoto, Hirofumi Ohnishi · 2022 · Metabolites
  6. Induction of fibroblast growth factor 21 does not require activation of the hepatic X-box binding protein 1 in mice
    Shantel Olivares, Anne S. Henkel · 2017 · Molecular Metabolism
  7. Acromegaly is associated with high fibroblast growth factor-21 levels
    Banu Şarer Yürekli, Nilüfer Özdemir Kutbay, Murat Akşit, Aslı Süner, İlgın Yıldırım Şimşir, Selda Seçkiner, Gökçen Ünal Kocabaş, Giray Bozkaya, Füsun Saygılı · 2018 · Journal of Endocrinological Investigation
  8. Emerging Circulating Biomarkers for The Diagnosis and Assessment of Treatment Responses in Patients with Hepatic Fat Accumulation, Nash and Liver Fibrosis
    Marta Iruarrizaga‐Lejarreta, Fernando Bril, Mazen Noureddin, P. Ortiz, Shelly Chi-Loo Lu, José María Mato, Cristina Alonso · 2019 · Springer eBooks
  9. Serum FGF21 in boys with idiopathic short stature: relationship to lipid profile, onset of puberty and growth*
    Matti T. Hero, Leo Dunkel, Kirsi Vaaralahti, Taneli Raivio · 2011 · Clinical Endocrinology
  10. Thymus Maintenance and Regeneration by Specific Molecular Factors
    Andrew R. Mendelsohn, James W. Larrick · 2016 · Rejuvenation Research
  11. Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide
    Sattar, Naveed, Linetzky, Bruno, Ruotolo, Giacomo, Verma, Subodh, Sourij, Harald, Wang, Hui, Vanderman, Kadie, Wilson, Jonathan M., Griffin, Ryan M., Stefanski, Adam et al. · 2026 · JACC
  12. Metabolic syndrome and kidney dysfunction: emerging molecular and cellular mechanisms at the metabolic–renal interface
    William R. Marshall, Darren Green, Smeeta Sinha, Philip A. Kalra · 2026 · Frontiers in Endocrinology
  13. Fibroblast Growth Factor 21: Mechanisms, Therapeutic Potential, and Clinical Translation in Metabolic Dysfunction
    Kaanthi Rama, Vinay Jahagirdar, Arun Jayant Sanyal · 2026 · Drug Design Development and Therapy
  14. Investigation of the Characteristics of Crimean Congo Hemorrhagic Fever Cases Reported in Afyonkarahisar Province
    Derya Korkmaz, Petek Şarlak Konya, Neşe Demirtürk · 2022 · Turkish Journal of Parasitology
  15. AOX delays the onset of the lethal phenotype in a mouse model of Uqcrh (complex III) disease
    Howard Trevor Jacobs, Marten Szibor, Birgit Rathkolb, Patricia da Silva‐Buttkus, Juan Antonio Aguilar‐Pimentel, Oana Veronica Amarie, Lore Becker, Julia Calzada‐Wack, Nathalia Romanelli Vicente Dragano, Lillian Garrett et al. · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  16. Activin E upregulates uncoupling protein 1 and fibroblast growth factor 21 in brown adipocytes
    Maho Sakaki, Yuji O. Kamatari, Akira Kurisaki, Masayuki Funaba, Osamu Hashimoto · 2024 · Molecular and Cellular Endocrinology
  17. Treating metabolic dysfunction‐associated steatohepatitis: The fat‐trimming FGF21 approach
    Xiaokun Li, Zhiheng Rao, Wenhao Hu, Weiqin Lu, Yongde Luo · 2024 · Obesity Reviews
  18. Hepatokine leukocyte cell‐derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction‐associated steatotic liver disease in the general population
    Keita Suzuki, Hiromasa Tsujiguchi, Akinori Hara, Yumie Takeshita, Hisanori Goto, Yujiro Nakano, Reina Yamamoto, Hiroaki Takayama, Atsushi Tajima, Tatsuya Yamashita et al. · 2024 · Journal of Diabetes Investigation
  19. Circulating fibroblast growth factor 21 is associated with blood pressure in the Chinese population: a community-based study
    Juanying Zhen, Shuyun Liu, Lin Liu, Xiaodan Zheng, Guoru Zhao, Jianguo Liang, Aimin Xu, Chao Li, Lijie Ren, Jun Wu et al. · 2025 · Annals of Medicine
  20. Circulating FGF21 vs. Stress Markers in Girls during Childhood and Adolescence, and in Their Caregivers: Intriguing Inter-Relations between Overweight/Obesity, Emotions, Behavior, and the Cared-Caregiver Relationship
    Eirini V. Christaki, Panagiota Pervanidou, Ioannis Papassotiriou, Aimilia Mantzou, Giorgos A. Giannakakis, Dario Boschiero, George Panagiotis Chrousos · 2022 · Children
  21. Effect of Aerobic Exercise Training on Circulating Fibroblast Growth Factor-21 Response to Glucose Challenge in Overweight and Obese Men: A Pilot Study
    Masahiro Matsui, Keisei Kosaki, Kanae Myoenzono, Toru Yoshikawa, Jieyon Park, Makoto Kuro‐o, Seiji Maeda · 2022 · Experimental and Clinical Endocrinology & Diabetes
  22. Association of circulating fibroblast growth factor 21 levels with all-cause and cardiovascular mortality: The multi-ethnic study of atherosclerosis
    William J. Tucker, Bradley Tucker, Andrzej S. Januszewski, Alicia Josephine Jenkins, ANTHONY C. KEECH, Bryan R. Kestenbaum, Matthew Allison, Kerry‐Anne Rye, Kwok Leung Ong · 2024 · Clinica Chimica Acta
  23. Association of brown adipose tissue activity with circulating sex hormones and fibroblast growth factor 21 in the follicular and luteal phases in young women
    Hirokazu Taniguchi, Yuka Hashimoto, Narumi Dowaki, Shinsuke Nirengi · 2024 · Journal of PHYSIOLOGICAL ANTHROPOLOGY
  24. Association of metabolic syndrome with serum fibroblast growth factor 21 in kidney transplanted patients
    Leila Bagheri, Maryam Hami, Mohammad Javad Mojahedi, Mahin Ghorban Sabbagh, Hosein Ayatollahi · 2016 · Journal of Renal Injury Prevention
  25. Treatment with FGFR2-IIIc monoclonal antibody suppresses weight gain and adiposity in KKAy mice
    Katsunori Nonogaki, Takao Kaji, T Yamazaki, Mari Murakami · 2016 · Nutrition and Diabetes
  26. Enteropathy Markers in Early Life Were Associated with Adipokine, Apolipoprotein, and Cytokine Profiles Consistent with an Adverse Cardiometabolic Disease Risk Profile Later in Childhood in a Peruvian Birth Cohort
    Josh Michael Colston, Yen‐Ting Chen, Patrick Hinson, Nhat-Lan H. Nguyen, Pablo Peñataro Yori, Maribel Paredes Olórtegui, Dixner Rengifo Trigoso, Mery Siguas Salas, Richard L. Guerrant, Ruthly François et al. · 2022 · American Journal of Tropical Medicine and Hygiene
  27. Plasma FGF21 Levels Are Not Associated with Weight Loss or Improvements in Metabolic Health Markers upon 12 Weeks of Energy Restriction: Secondary Analysis of an RCT
    Anouk Gijbels, Sophie Schutte, Diederik Esser, Charlotte C. J. R. Michielsen, Els Siebelink, Monica Mars, Marco Mensink, Lydia A. Afman · 2022 · Nutrients
  28. High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients
    Fei Han, Ling Yin, Xiaoping Yu, Renyan Xu, Mingxiang Tian, Xinnong Liu, Lu Zhou, Liang‐Hao Hu, Weijuan Gong, Weiming Xiao et al. · 2023 · PeerJ
  29. Hepatic miR‑215 target Rictor and modulation of hepatic insulin signalling in rats
    Weidong Li, Xia Jin-rong, Yan‐Shu Lian · 2019 · Molecular Medicine Reports
  30. NEW INSIGHTS INTO BROWN ADIPOSE TISSUE AS A PHARMACOLOGICAL TARGET IN OBESITY
    Ana Marina Andrei · 2020 · FARMACIA
  31. Fibroblast Growth Factor 21 in Patients with Acromegaly
    Jowita Halupczok-Żyła, Aleksandra Jawiarczyk-Przybyłowska, Marek Skrzypski, Mathias Z. Strowski, Marek Bolanowski · 2017 · Experimental and Clinical Endocrinology & Diabetes
  32. The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition
    Maria Moreno-Lopez, Isaline Louvet, Nathalie Delalleau, Ana Acosta-Montalvo, Julien Thévenet, Gianni Pasquetti, Valéry Gmyr, Julie A. Kerr-Conte, François N. Pattou, Caroline Bonner et al. · 2024 · Diabetes Obesity and Metabolism
  33. Maternal obesity impairs fetal brown adipogenesis by attenuating fetal FGF21 signaling
    Lun Hua, Wen Shen, Dengfeng Gao, Yi Yang, Xiaohan Yang, Haoqi Zhang, Siyuan Liu, Luting Liu, Yaxue Cao, Xuemei Jiang et al. · 2025 · Cell Reports
  34. Plasma Levels of Fibroblast Growth Factor 21 and Adverse Kidney Outcomes
    Hee Byung Koh, Hyo Jeong Kim, Hyung Woo Kim, Tae Ik Chang, Jung Tak Park, Tae‐Hyun Yoo, Shin‐Wook Kang, Seung Hyeok Han · 2025 · Mayo Clinic Proceedings
  35. FGF21 restores metabolic function in Alzheimer’s disease via activation of PI3K/Akt signaling
    Feng Zhao, Hui Yang, Huamei Liu, Heming Yu, Yang Zhao · 2025 · Neurological Research
  36. Can Myokines Serve as Supporters of Muscle–Brain Connectivity in Obesity and Type 2 Diabetes? Potential of Exercise and Nutrition Interventions
    Heaji Lee, Yunsook Lim · 2025 · Nutrients
  37. Whole-brain Mapping Reveals Diet-dependent Neuronal Activation and Selective Resistance to Exogenous FGF21
    Jieyi Meng, Xi Chen, Yi Zhu · 2025 · Endocrinology
  38. Exploring the correlation between serum fibroblast growth factor-21 levels and Sarcopenia: a systematic review and meta-analysis
    Hao Liu, Xiayun He, Xiaoyan Deng, Jing-Lu Yan · 2023 · BMC Musculoskeletal Disorders
  39. The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
    Lili You, Xiaosi Hong, Hongshi Wu, Diefei Liang, Feng Li, Dinghao Zheng, Xiuwei Zhang, Dan Liu, Qingyu Chen, Li Yan et al. · 2023 · BMC Endocrine Disorders
  40. Fibroblast Growth Factor 21 Predicts Type 2 Diabetes in Taiwanese
    Shih‐Li Su, Cheng‐Ling Kuo, Ching‐Shan Huang, Chin-Shan Liu · 2013 · Zānghuà yīxué
  41. Mitochondrial Respiratory Disorders: A Perspective on their Metabolite Biomarkers and Implications for Clinical Diagnosis and Therapeutic Intervention.
    Martine N. Uittenbogaard, Anne Chiaramello · 2015 · PubMed
  42. Hepatic Fat Content Is Associated with Fasting-Induced Fibroblast Growth Factor 21 Secretion in Mice Fed Soy Proteins
    Hirokazu Taniguchi, Nao Akiyama, Kengo Ishihara · 2019 · Journal of Nutritional Science and Vitaminology
  43. Bibliometric analysis of fibroblast growth factor 21 research over the period 2000 to 2021
    Qin-Ying She, Lijuan Li, Ming-Hong Liu, Ru-Yu Tan, Yi-Wen Zhong, Jing‐Fu Bao, Jie-Dong Xie · 2022 · Frontiers in Pharmacology
  44. Sitagliptin reduces FAP-activity and increases intact FGF21 levels in patients with newly detected glucose abnormalities
    Anne K.N. Pedersen, Camilla Hage, Niels Jessen, Linda Mellbin, Mette Bjerre · 2022 · Molecular and Cellular Endocrinology
  45. Serum Level of Fibroblast Growth Factor 21 in Type 2 Diabetic Patients with and without Metabolic Syndrome
    Azam Shafaei, Masoud Khoshnia, Abdoljalal Marjani · 2015 · Journal of Medical Sciences(Faisalabad)
  46. Association of circulating FGF-21 levels in the first week of life and postnatal growth in hospitalized preterm infants
    Kyoung Eun Joung, Dana M. Clausen, Aimee R. Herdt, Amy Presti, Ruth Snyder, Caryn Peters, Helen A. Christou, Christos Socrates Mantzoros · 2020 · Metabolism Open
  47. Fibroblast growth factor-21 levels in metabolic syndrome: Another instrument in a widening tool belt?
    Oluremi N Ajala, Samia Mora · 2018 · Atherosclerosis
  48. Connecting the Dots: FGF21 as a Potential Link between Obesity and Cardiovascular Health in Acute Coronary Syndrome Patients
    Cristina Elena Negroiu, Anca‐Lelia Riza, Ioana Streață, Iulia Tudorașcu, Cristina Maria Bezna, Adrian Ungureanu, Suzana Dănoiu · 2024 · Current Issues in Molecular Biology
  49. Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring
    Yafeng Li, Wenzhu Song, Chengyu Huan, Keman Xu, Juan Sun, Xin Zhen, Hua Ouyang, Hairong Tang, Qiuxia Fan, Wenqiang Zhi et al. · 2026 · Pharmacology & Therapeutics
  50. FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism
    Ewa Szczepańska, Piotr Glinicki, Wojciech Zgliczyński, Jadwiga Slowinska-Srzednicka, Helena Jastrzębska, Małgorzata Gietka‐Czernel · 2022 · Frontiers in Endocrinology
  51. Maternal organokines throughout pregnancy as predictors of neonatal anthropometric characteristics and adiposity
    Jorge Valencia‐Ortega, Victoria Galicia-Hernández, Andrea Castillo-Santos, Miranda Molerés-Orduña, Carla Arceo-Cerna, Otilia Perichart‐Perera, Ameyalli Mariana Rodríguez-Cano, Carolina Rodríguez-Hernández, Guadalupe Estrada‐Gutiérrez, Ignacio Camacho‐Arroyo et al. · 2024 · Frontiers in Endocrinology
  52. The Impact of Human Liver Transplantation on the Concentration of Fibroblast Growth Factors: FGF19 and FGF21
    Marta Budkowska, Ewa Ostrycharz, Elżbieta Cecerska‐Heryć, Katarzyna Dołęgowska, Aldona Siennicka, Łukasz Nazarewski, Paweł Rykowski, Barbara Dołęgowska · 2025 · International Journal of Molecular Sciences
  53. BIOMARKER QUANTITATION: ANALYTICAL CONSIDERATIONS FOR LIGAND BINDING ASSAY REGRESSION CURVES AND QUALITY CONTROL SAMPLES
    Dysinger · 2012 · American Journal of Immunology
  54. Genetics of Energy and Macronutrient Intake in Humans
    Toshiko Tanaka · 2014 · Current Nutrition Reports
  55. Relationship between fibroblast growth factor 21 and thyroid stimulating hormone in healthy subjects without components of metabolic syndrome
    Tianxu Fu, Shanshan Yuan, Ying Gao, Chenxue Qu, Lan Chen, Hui Yan, Guizhi Lu, Yanming Gao, Xiaohui Guo · 2014 · Family Medicine and Community Health
  56. Possible role of gingival crevicular fluid levels of Chemerin and Fibroblast growth factor 21 as biomarkers of periodontal disease in diabetic and non-diabetic patients. A diagnostic accuracy study
    Eman Mohammad Amr, Rasha Mostafa, Olfat Gamil Shaker · 2019 · Advanced Dental Journal
  57. No strong evidence of the protein leverage hypothesis in pregnant women with obesity and their infants
    Maryam Kebbe, Jasper Most, Abby D. Altazan, Leanne Maree Redman · 2023 · Obesity
  58. Mitochondrial respiratory complex I deficiency inhibits brown adipogenesis by limiting heme regulation of histone demethylation
    Jingjing Liu, Wen Lu, Dongyue Yan, Junyuan Guo, Li Zhou, Bimin Shi, Xiong Su · 2023 · Mitochondrion
  59. Changes in metabolic hormones and trace elements in CSF in active smokers indicate oxidative damage to brain cells
    Peiwen Zheng, Fan Wang, Hui Li, Hanlu Chen, Meng-Tong Li, Haozheng Ma, Jue He, Li Chen, Yanlong Liu, Haiyun Xu · 2024 · Endocrine Connections
  60. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model
    Kateřina Horská, Jan Kucera, Eva Dražanová, Gabriela Kuzmínová, Petra Amchová, Maria Hrickova, Jana Kučerová, Silje Skrede · 2024 · Biomedicine & Pharmacotherapy
  61. A Tryptophan Hydroxylase Inhibitor Increases Hepatic FGF21 Production and Decreases Hepatic Gluconeogenesis Independently of Insulin in db/db Mice
    Katsunori Nonogaki, Takao Kaji, Mari Murakami · 2018 · Neuropsychiatry
  62. Comparative Effect of Aqueous and Methanolic Bupleuri Radix Extracts on Hepatic Uptake of High-Density Lipoprotein and Identification of the Potential Target in HFD-Fed Mice
    Zhibin Tan, Yijia Huang, Fenglian Chen, Cheng Cao, Shuling Wang · 2019 · Evidence-based Complementary and Alternative Medicine
  63. Pharmacologic inhibition of serotonin htr2b ameliorates hyperglycemia and the altered expression of hepatic FGF21, Sdf2l1, and htr2a in db/db mice and KKAy mice
    Katsunori Nonogaki, Takao Kaji · 2020 · Heliyon
  64. Maternal Blood-Based Protein Biomarkers in Relation to Abdominal Fat Distribution Measured by Ultrasound in Early Mid-Pregnancy
    Emelie Lindberger, Anna‐Karin Wikström, Inger Sundström Poromaa, Fredrik Ahlsson · 2022 · Reproductive Sciences
  65. Evaluation of Serum Adropin Levels in Type 2 Diabetic Patients and Its Correlation with Insulin Resistance
    Niranjan Shah, Pallavi Anand, Shrawan Kumar, Pawan Arun Kulkarni · 2021 · Journal of Datta Meghe Institute of Medical Sciences University
  66. The FGF Family in Humans, Mice, and Zebrafish: Development, Physiology, and Pathophysiology
    Sayaka Sasaki, Hiroya Ohta, Yoshiaki Nakajima, Morichika Konishi, Ayumi Miyake, Nobuyuki Itoh · 2011 · InTech eBooks
  67. Fibroblast Growth Factor 21 is a Regulator of Energy Metabolism in the Liver and Adipose Tissue
    Niina Matikainen · 2014 · Elsevier eBooks
  68. Fibroblast growth factor-21 is a novel linkage between metabolic parameters, cardiovascular risk, and nephropathy in prediabetes
    RagaaA Matta, Sahar Hossam El-Hini, Mahmood Saad, Hanan Mostafa, Ahmed AbedelfadeeL · 2017 · Egyptian Journal of Obesity Diabetes and Endocrinology
  69. FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
    Judita Klímová, Tomáš Zelinka, Ján Rosa, Branislav Štrauch, D Haluzíková, Martin Haluzı́k, Robert Holaj, Zuzana Krátká, Jan Kvasnička, Viktorie Ďurovcová et al. · 2019 · Cancers
  70. Identificación del fenotipo ahorrador para la personalización del manejo del sobrepeso y la obesidad
    Fernando Carrasco N, Gabriela Noemí Carrasco Navarro · 2022 · Revista Médica Clínica Las Condes
  71. Study of FGF21 Levels in Transgender People and its Association with Metabolic Parameters
    Lohit Kumbar, Baratam Hari Kiran, Mala Dharmalingam, Pramila Kalra · 2023 · Indian Journal of Endocrinology and Metabolism
  72. FGF-21 Level is higher in patients with breast cancer, a candidate for a new biomarker?
    Zeynep Şahiner, Anara Karaca, Filiz Bakar‐Ates, Gökhan Giray Akgül, Mehmet Ali Gülçelik, Neşe Ersöz Gülçelik · 2024 · Anatolian Current Medical Journal
  73. Impact of cold exposure on shift working seafood handlers in Northern Norway: a comparative analysis across work shifts
    Phong KT. Chau, Tiril Schjølberg, Mina Baarnes Eriksen, Anne-Mari Gjestvang Moe, Pål Graff, Fred Haugen · 2025 · Journal of Occupational Medicine and Toxicology
  74. B1344 ameliorates non-alcoholic steatohepatitis in HFCD-HF/G-induced mice: exploring the therapeutic efficacy and mechanism of a novel FGF21 analogue
    Zhiwei Chen, Tao Liu, Ping Huang, Yang Liu, Siyu Xu, Junyao Ding, Haiyan Song, Lili Yang, Peiyong Zheng · 2025 · European Journal of Pharmacology
  75. Relationship Between Adipose Tissue and Liver Dysfunction in Women with Polycystic Ovary Syndrome and Metabolic Syndrome
    Sebastião Freitas de Medeiros, Gustavo Arantes Rosa Maciel · 2026 · Metabolites
  76. Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
    Niina Matikainen, Sanni Söderlund · 2019 · Elsevier eBooks
  77. The elevation of fibroblast growth factor 21 is associated with generalized periodontitis in patients with treated metabolic syndrome
    Teerat Sawangpanyangkura, Panwadee Bandhaya, Pattanin Montreekachon, Anongwee Leewananthawet, Arintaya Phrommintikul, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn · 2022 · BMC Oral Health
  78. FGF21 increases the sensitivity of hepatocellular carcinoma to sorafenib under hypoxia
    Ting Zhang, Huiling Shi, Shihui Zhang, Qin Zhu, Mengyuan Qiu, Ashleigh Tinotenda Chitakunye, Hanyu Hong, Liaoxin Luo, Yujing Li, Qiuyu Sun et al. · 2024 · Malignancy Spectrum
  79. Glucosamine Enhancement of Learning and Memory Functions by Promoting Fibroblast Growth Factor 21 Production
    Yu-Ming Chao, Hon‐Yen Wu, Sin-Huei Yeh, Ding‐I Yang, Lu‐Shiun Her, Yuh-Lin Wu · 2024 · International Journal of Molecular Sciences
  80. Analysis of serum levels and DNA methylation of fibroblast growth factor 21 using peripheral blood-derived genomes in patients with obesity
    Hiroyuki Shinozaki, Shiori Kawai, Mami Gamo-Kawasaki, Ayano Takei, Kyoko Tsujikado, Kazunori Fukuda, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Kohzo Takebayashi et al. · 2024 · Endocrine Journal
  81. Serum FGF-21 Levels During COVID-19 Infection Recovery Period
    A. Dilara Demir, Zeynep Cetin, Fikriye Milletli Sezgin · 2024 · Medical Bulletin of Haseki
  82. Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study
    Yolanda Real‐Martínez, Carlos Ernesto Fernandez‐Garcia, Esther Fuertes-Yebra, Mario Calvo Soto, Ángela Berlana, Vicente Barrios, María Caldas, Leticia González‐Moreno, Luisa Garcı́a-Buey, Begoña Molina Baena et al. · 2025 · World Journal of Gastroenterology
  83. The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice
    Angelo Di Vincenzo, Marnie Granzotto, Marika Crescenzi, Paola Fioretto, Roberto Vettor, Marco Rossato · 2025 · BMC Endocrine Disorders
  84. Serum FGF21 Levels in Obese Korean Children and Adolescents (J Obes Metab Syndr 2017;26:204-9)
    Young‐Jun Rhie, Kee‐Hyoung Lee · 2017 · Journal of Obesity & Metabolic Syndrome
  85. Adiponectin: A Perspective Adipose Tissue Marker with Antiinflammatory and Antiaterogenic Potencial
    Dalibor Novotný, H Vaverková, David Karásek · 2012 · InTech eBooks
  86. The impact of LDLR function on fibroblast growth factor 21 levels
    Joost Besseling, Kwok Leung Ong, Roeland Huijgen, Kerry‐Anne Rye, G. Kees Hovingh, Barbara A. Hutten, Gilles C. Lambert · 2015 · Atherosclerosis
  87. Fibroblast growth factor-21: A link for glucose homeostasis
    Ebrahim Khalil Naderali, Christopher Wong, Munir Hussain · 2009 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  88. The Potential Impact of Maternal Milk Consumption During Pregnancy on mTORC1-Driven Fetal Growth
    Bodo Clemens Melnik · 2016 · Springer eBooks
  89. Fibroblast growth factor 21: new insights from human studies
    Jakob Schiøler Hansen, Peter Plomgaard · 2016 · Cardiovascular Endocrinology
  90. Anti-adiposity impact of phosphodiesterase-5 inhibitor, Sildenafil is possibly through browning of white adipose tissue and FGF21 in obese rats
    Marwa Muhammad, Sania Elwai, Shaymaa Abd El Rahman · 2019 · Bulletin of Egyptian Society for Physiological Sciences
  91. Soluble angiotensin-converting enzyme 2 association with lipid metabolism
    Izumi Nagatomo, Kaori Nakanishi, Ryohei Yamamoto, Seiko Ide, Chisaki Ishibashi, Toshiki Moriyama, Keiko Yamauchi‐Takihara · 2022 · Frontiers in Medicine
  92. Neuroendocrine dysregulation and the growth hormone–IGF-1 axis in anorexia nervosa
    Pouneh K. Fazeli, Anne Klibanski · 2012 · Expert Review of Endocrinology & Metabolism
  93. Association between circulating fibroblast growth factor 21, aerobic fitness, and aortic blood pressure in middle-aged and older women
    Masahiro Matsui, Keisei Kosaki, Nobuhiko Akazawa, Koichiro Tanahashi, Makoto Kuro‐o, Seiji Maeda · 2019 · The Journal of Physical Fitness and Sports Medicine
  94. Fibroblast Growth Factor 21 as a Novel Metabolic Regulator
    Radmila Micanovic, James D. Dunbar, Alexei Kharitonenkov · 2011
  95. A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
    Asmaa Elsayed · 2020 · The Sydney eScholarship Repository (The University of Sydney)
  96. Endogenous GDF15 and FGF21 additively alleviate hepatic steatosis and insulin resistance in obese mice
    Satish Patel, Afreen Haider, Anna Álvarez-Guaita, Guillaume Bidault, Julia S. El-Sayed Moustafa, Esther Guiu‐Jurado, John A. Tadross, James Warner, James Harrison, Sam Virtue et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Mitochondrial and Stress-Related Psychobiological Regulation of FGF21 in Humans
    Mangesh Kurade, Natalia Bobba‐Alves, Catherine Kelly, Alexander Behnke, Quinn A. Conklin, Robert‐Paul Juster, Michio Hirano, Caroline Trumpff, Martin A. Picard · 2025 · medRxiv
  98. The role of fibroblast growth factor 21 in metabolic processes in patients with gastrointestinal diseases
    Yu.М. Stepanov, L.М. Mosiychuk, І.А. Кленіна, О.М. Tatarchuk, О.П. Петішко, O.M. Shevtsova · 2024 · GASTROENTEROLOGY
  99. Plasma FGF21 Concentration in Kidney Transplant Patients—Results from Prospective and Cross-Sectional Studies
    Magdalena Bartmańska, Andrzej Więcek, Marcin Adamczak · 2024 · Journal of Clinical Medicine
  100. Serum fibroblast growth factor 21: Lack of association with gestational diabetes and pregnancy outcomes
    Kuntharee Traisrisilp, Nattayaporn Apaijai, Nipawan Waisayanand, Siriporn Chattipakorn · 2024 · World Journal of Obstetrics and Gynecology